Home > Insider Trading > Filing (0001140361-13-018633)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1238403	K Daniel Spiegelman	105 Digital Drive Novato CA 94949	Evp, Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-05-01	28,000	$39.06	61,000	No	4	M	Direct
Common Stock	Disposition	2013-05-01	28,000	$64.42	33,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2013-05-01	28,000	$0.00	28,000	$39.06

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
97,000	2012-11-29	2022-05-28	No	4	M	Direct

Footnotes

The price in column 4 is a weighted average price. The price actually received ranged from $63.96 to $64.65. The reportng person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.
Original option grant vests 6/48th on November 29, 2012 and 1/48th each on the 29th of each month thereafter.